Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion Pharmaceuticals is harnesing the power of artificial intelligence to rapidly develop new drugs. The drugmaker's former lead candidate failed to show evidence of efficacy in a phase 2 study ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Samsungに所属するAI研究者のAlexia Jolicoeur-Martineau氏が小型かつ高性能なAIモデル「Tiny Recursion Model(TRM)」を開発しました。TRMは再帰的推論と呼ばれる手法を採用しており、わずか700万パラメーターという小型モデルでありながらGemini 2.5 Proを超えるベンチマーク ...